Peering Into Horizon Therapeutics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Horizon Therapeutics's (NYSE:HZNP) short percent of float has fallen 25.18% since its last report, with 7.10 million shares sold short, which is 3.12% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. However, it does not necessarily mean that the stock price will rise in the near term. Compared to its peers, Horizon Therapeutics has less short interest.
October 05, 2023 | 8:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Horizon Therapeutics's short interest has decreased, which could indicate a more bullish sentiment towards the stock. However, this does not guarantee a rise in the stock price.
A decrease in short interest usually indicates that traders are less bearish on the stock, which could potentially lead to an increase in the stock price. However, other factors such as company performance, market conditions, and investor sentiment also play a significant role in determining the stock price. Therefore, while the decrease in short interest is a positive sign, it does not guarantee a rise in Horizon Therapeutics's stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100